Welcome to our dedicated page for National Research Corporation news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Research Corporation stock.
National Research Corporation Common Stock (Delaware) (symbol: NRC) is dedicated to enhancing the experiences of patients, residents, and healthcare providers for over 35 years. Operating primarily in the United States and Canada, NRC Health provides analytics and insights that help healthcare organizations measure and improve patient and employee experiences, fostering greater engagement and loyalty.
NRC Health's offerings include a wide range of solutions that deliver value to its clients by enabling a deeper understanding of the individuals they serve. This holistic approach includes proprietary methods and tools that aid healthcare systems in designing experiences that build trust and inspire loyalty. These solutions are critical for healthcare providers, payers, and other organizations aiming to improve care delivery and patient outcomes.
In recent developments, NRC Health has partnered with LifeBridge Health, one of Maryland’s largest health systems, to implement the Human Understanding® program. This partnership, highlighted by NRC Health’s comprehensive data-driven insights and personalized healthcare solutions, aims to enhance patient care and satisfaction through innovative, human-centered approaches. The collaboration also involves administering the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey to ensure consistent quality measures.
Financially, NRC Health remains robust, drawing significant revenue from its United States operations. Its focused market research, patient-centered initiatives, and consumer preference data have earned NRC Health a top ranking for Patient Experience Improvement in the 2023 Best in KLAS report.
For more information about NRC Health, their services, or recent updates, visit www.nrchealth.com. You can also contact them at 800-388-4264 or via email at info@nrchealth.com.
NRC Health has awarded the 2021 Rising Stars Scholarship to Hunter Bergman and Lauren Lewis, both students at the University of Nebraska-Lincoln. Each recipient will receive $2,000 for the spring 2022 semester. The scholarship aims to support students interested in business development, marketing, and entrepreneurship. Hunter, a senior marketing major, is the President of StartupsUNL, while Lauren is a junior marketing major and has worked on campaigns for international non-profits. The program, initiated in 2011, highlights NRC Health's commitment to education and student engagement.
National Research Corporation (NASDAQ:NRC) reported a strong Q3 2021, with total recurring contract value reaching $151.5 million. Revenue increased 13% to $37.8 million, while operating income rose 9% to $13.1 million. The company experienced a 20% growth in Voice of the Customer offerings, gaining new clients like Sharp Healthcare and UConn Health. Year-to-date revenue increased 11% to $109.7 million. However, net income saw a slight decrease to $27.8 million compared to $29 million in 2020, attributed to a higher effective tax rate.
National Research Corporation (NASDAQ:NRC) has declared a quarterly cash dividend of $0.12 per share. This dividend will be payable on October 15, 2021, to shareholders of record by the close of business on September 30, 2021. NRC has established itself as a leading provider of analytics and insights to enhance human understanding for over 40 years, showcasing its commitment to shareholder returns.
National Research Corporation reported strong Q2 2021 results, achieving a 17% revenue increase to $36.4 million and a 32% rise in operating income to $12.2 million. The total recurring contract value grew 5% to $149.8 million, driven by a 29% boost in Voice of the Customer offerings. The cash balance increased to $48.9 million. However, the effective tax rate rose to 25% from 10% in the previous year, impacting net income which reached $8.9 million, up from $7.7 million. The company focuses on organic growth and enhancing client relationships.
National Research Corporation (NASDAQ:NRC) declared a quarterly cash dividend of $0.12 per share, payable July 15, 2021. Shareholders on record by June 30, 2021 will receive this dividend. With over 40 years of experience, NRC remains a leading provider of analytics and insights aimed at enhancing human understanding.
FAQ
What is the current stock price of National Research Corporation (NRC)?
What is the market cap of National Research Corporation (NRC)?
What services does NRC Health provide?
Where does NRC Health operate?
What is the Human Understanding® program?
Who are NRC Health's recent partners?
What is the CAHPS survey?
How long has NRC Health been in operation?
What distinguishes NRC Health in the market?
How can I contact NRC Health?
What type of organizations benefit from NRC Health's services?
How does NRC Health support healthcare organizations?
